Filters
Use basic filters below or open advanced options for more precise results.
Last dataset refresh: 27 Jun 2026
| Product name | Classification | Strength | Form | Manufacturer | Country of origin | Status | Registered On | Action | |
|---|---|---|---|---|---|---|---|---|---|
|
ILARIS® 150 mg/ml
|
Biological Medicines | 150 mg/ml | Injection | Lek Pharmaceuticals d.d., Slovenia, Ljubljana | Ireland | Active | 13 Sep 2017 | View details → | |
|
iliadin™ 0.05% Nasal Spray
|
Conventional Medicines | 0.5 mg/ml | Spray | FAMAR HEALTH CARE SERVICES MADRID, S.A.U, Spain, Alcorcon (Madrid) | Germany | Active | 07 Feb 2018 | View details → | |
|
iliadin™ BABY 0.01% Nasal Drops
|
Conventional Medicines | 0.1 mg/ml | Drops | FAMAR HEALTH CARE SERVICES MADRID, S.A.U, Spain, Alcorcon (Madrid) | Germany | Active | 07 Feb 2018 | View details → | |
|
iliadin™ KIDS 0.025% Nasal Spray
|
Conventional Medicines | 0.25 mg/ml | Spray | FAMAR HEALTH CARE SERVICES MADRID, S.A.U, Spain, Alcorcon (Madrid) | Germany | Active | 07 Feb 2018 | View details → | |
|
illuma 1 RTF
|
GSL Products | Combination | Liquid | Nestle Deutschland AG, Germany, Biessenhofen | Germany | Active | 09 Jun 2022 | View details → | |
|
Illuma® 1
|
GSL Products | combination | Powder | NESTLE SUISSE S.A, Switzerland, konolfingen | Switzerland | Active | 05 Jan 2022 | View details → | |
|
Illuma® 1
|
GSL Products | combination | Powder | NESTLE SUISSE S.A, Switzerland, konolfingen | Switzerland | Active | 05 Jan 2022 | View details → | |
|
illuma® 2
|
GSL Products | combination | Powder | NESTLE SUISSE S.A, Switzerland, konolfingen | Switzerland | Active | 09 Jun 2022 | View details → | |
|
illuma® 2
|
GSL Products | combination | Powder | NESTLE SUISSE S.A, Switzerland, konolfingen | Switzerland | Active | 09 Jun 2022 | View details → | |
|
illuma® 3
|
GSL Products | Combination | Powder | NESTLE SUISSE S.A, Switzerland, konolfingen | Switzerland | Active | 09 Jun 2022 | View details → | |
|
illuma® 3
|
GSL Products | Combination | Powder | NESTLE SUISSE S.A, Switzerland, konolfingen | Switzerland | Active | 09 Jun 2022 | View details → | |
|
Ilumya® 100 mg per ml
|
Biological Medicines | 100mg/1ml | Injection | HIKMA PHARMACEUTICALS, Jordan, Amman | Jordan | Active | 30 Jun 2022 | View details → | |
|
ILUVIEN®
|
Conventional Medicines | 0.19 mg/Implant | Implant | ALLIANCE MEDICAL PRPODUCTS, Inc. dba siegfried irvine, United States of America, Irvine | United States of America | Active | 07 Feb 2018 | View details → | |
|
Ima-Denk 100 mg
|
Conventional Medicines | 100 mg/tablet | Tablet | Haupt Pharma Amareg GmbH, Germany, Regensburg | Germany | Active | 29 Sep 2016 | View details → | |
|
Ima-Denk 400 mg
|
Conventional Medicines | 400 mg/tablet | Tablet | Haupt Pharma Amareg GmbH, Germany, Regensburg | Germany | Active | 29 Sep 2016 | View details → | |
|
IMADEV 400 mg
|
Conventional Medicines | 400 mg/Tablet | Tablet | DEVA HOLDING A.S, Turkey, Tekirdag | Turkey | Active | 06 Dec 2017 | View details → | |
|
Imalar 100 mg
|
Conventional Medicines | 100mg | Tablet | Sudair Pharma company, Saudi Arabia, Riyadh | Saudi Arabia | Active | 13 Apr 2020 | View details → | |
|
Imalar 400 mg
|
Conventional Medicines | 400mg | Tablet | Sudair Pharma company, Saudi Arabia, Riyadh | Saudi Arabia | Active | 13 Apr 2020 | View details → | |
|
Imatance-100
|
Conventional Medicines | 100 mg/Tablet | Tablet | Adcan Pharma, United Arab Emirates, Abu Dhabi | United Arab Emirates | Active | 30 Oct 2024 | View details → | |
|
Imatance-400
|
Conventional Medicines | 400 mg/Tablet | Tablet | Adcan Pharma, United Arab Emirates, Abu Dhabi | United Arab Emirates | Active | 30 Oct 2024 | View details → | |
|
Imatox® 4 mg
|
Conventional Medicines | 4mg/ tablet | Tablet | TABUK PHARMACEUTICAL MANUFACTURING CO., Saudi Arabia, Tabuk | Saudi Arabia | Active | 04 Feb 2021 | View details → | |
|
Imatox® 4 mg/2 ml
|
Conventional Medicines | 2 mg/ml | Injection or Infusion | Tabuk Pharmaceutical Manufacturing Co, Saudi Arabia, Dammam | Saudi Arabia | Active | 22 Oct 2020 | View details → | |
|
Imatox® 8 mg
|
Conventional Medicines | 8mg/tablet | Tablet | TABUK PHARMACEUTICAL MANUFACTURING CO., Saudi Arabia, Tabuk | Saudi Arabia | Active | 04 Feb 2021 | View details → | |
|
Imatox® 8 mg/4 ml
|
Conventional Medicines | 8mg /4ml | Injection or Infusion | Tabuk Pharmaceutical Manufacturing Co, Saudi Arabia, Dammam | Saudi Arabia | Active | 22 Oct 2020 | View details → |
Compare selected products
0 of 3 selected